{"id":742462,"date":"2024-02-07T08:30:00","date_gmt":"2024-02-07T07:30:00","guid":{"rendered":"https:\/\/www.capgemini.com\/fr-fr\/?post_type=press-release&#038;p=742462"},"modified":"2025-03-04T08:44:29","modified_gmt":"2025-03-04T07:44:29","slug":"les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe","status":"publish","type":"press-release","link":"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/","title":{"rendered":"Les grandes entreprises pharmaceutiques investiront pr\u00e8s de 7% de leur chiffre d&#8217;affaires dans la cr\u00e9ation d&#8217;environnements de laboratoire connect\u00e9s et de pointe d&#8217;ici \u00e0 2025"},"content":{"rendered":"\t\t<div class=\"wp-block-cg-blocks-hero-press-release\">\n\t\t\t<header class=\"header-hero-press-release\" role=\"main\" id=\"main-content-press-release\">\n\t\t\t\t<div class=\"container\">\n\t\t\t\t\t<div class=\"hero-press-release\">\n\t\t\t\t\t\t<div class=\"hero-press-release-content-wrapper\">\n\t\t\t\t\t\t\t<div class=\"row\">\n\t\t\t\t\t\t\t\t<div class=\"col-12\">\n\t\t\t\t\t\t\t\t\t<div class=\"header-title\">\n\t\t\t\t\t\t\t\t\t\t<h1>\n\t\t\t\t\t\t\t\t\t\t\tLes grandes entreprises pharmaceutiques investiront pr\u00e8s de 7% de leur chiffre d&#8217;affaires dans la cr\u00e9ation d&#8217;environnements de laboratoire connect\u00e9s et de pointe d&#8217;ici \u00e0 2025\t\t\t\t\t\t\t\t\t\t<\/h1>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"header-description\">\n\t\t\t\t\t\t\t\t\t\t<p>Les environnements de laboratoire de nouvelle g\u00e9n\u00e9ration sont d\u00e9sormais essentiels pour les th\u00e9rapies innovantes, la r\u00e9duction des d\u00e9lais de mise sur le march\u00e9 et l&#8217;am\u00e9lioration des taux d&#8217;approbation, mais la plupart d&#8217;entre eux sont encore en phase pilote.<\/p>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"header-date\">\n\t\t\t\t\t\t\t\t\t\t<span>f\u00e9vr. 7, 2024<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"hero-press-release-downloads\">\n\t\t\t\t\t\t\t\t<div class=\"row\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"col-12 col-md-6 col-lg-3\">\n\t\t\t\t\t\t\t\t\t\t\t<a class=\"download-item\" type=\"download\" href=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2024\/02\/02_07_Lab-of-the-future_Group-news-alert.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"Ouvrir dans une nouvelle fen\u00eatre\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"download-icon\"><\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"download-details\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"download-title\">Download press release<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"download-props\">149 KB  pdf<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"col-12 col-md-6 col-lg-3\">\n\t\t\t\t\t\t\t\t\t\t\t<a class=\"download-item\" type=\"download\" href=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2024\/02\/Final-Infographic-Lab-of-the-Future.pdf\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"Ouvrir dans une nouvelle fen\u00eatre\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"download-icon\"><\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"download-details\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"download-title\">Download infographic<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"download-props\">875 KB  pdf<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"hero-press-release-brand-image\">\n\t\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/themes\/capgemini2025\/assets\/images\/capgemini-research-institute-white.svg\" alt=\"Logo de la marque\" \/>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/header>\n\t\t<\/div>\n\t\t\n\n\n<section class=\"wp-block-cg-blocks-group undefined section section--article-content\"><div class=\"article-main-content\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-1\"><nav class=\"article-social\"><ul class=\"social-nav\"><li class=\"ip-order-fb\"><a href=\"https:\/\/www.facebook.com\/sharer\/sharer.php?=http:\/\/capgeminiucwe.develop\/?post_type=press-release&amp;p=179\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"Ouvrir dans une nouvelle fen\u00eatre\"><i aria-hidden=\"true\" class=\"icon-fb\"><\/i><span class=\"sr-only\">Facebook<\/span><\/a><\/li><li class=\"ip-order-tw\"><a href=\"https:\/\/twitter.com\/intent\/tweet?=http:\/\/capgeminiucwe.develop\/?post_type=press-release&amp;p=179\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"Ouvrir dans une nouvelle fen\u00eatre\"><i aria-hidden=\"true\" class=\"icon-tw\"><\/i><span class=\"sr-only\">Twitter<\/span><\/a><\/li><li class=\"ip-order-li\"><a href=\"https:\/\/www.linkedin.com\/shareArticle?=http:\/\/capgeminiucwe.develop\/?post_type=press-release&amp;p=179\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"Ouvrir dans une nouvelle fen\u00eatre\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><span class=\"sr-only\">Linkedin<\/span><\/a><\/li><\/ul><\/nav><\/div><div class=\"col-12 col-md-11 col-lg-10\"><div class=\"article-text article-quote-text\">\n<p><strong>Les initiatives de transformation des laboratoires se multiplient<\/strong><\/p>\n\n\n\n<p>Les grandes entreprises pharmaceutiques<a id=\"_ftn2\" href=\"#_ftnref2\">[1]<\/a> pr\u00e9voient d&#8217;augmenter leurs investissements dans la transformation de leurs laboratoires, passant de 4 % \u00e0 pr\u00e8s de 7 % de leurs revenus d&#8217;ici 2025. Ces laboratoires &#8220;nouvelle g\u00e9n\u00e9ration&#8221;<a id=\"_ftn1\" href=\"#_ftnref1\">[2]<\/a>, ax\u00e9s sur la num\u00e9risation, l&#8217;intelligence artificielle et l&#8217;am\u00e9lioration des processus, sont essentiels pour acc\u00e9l\u00e9rer le d\u00e9veloppement de th\u00e9rapies innovantes, r\u00e9duire les d\u00e9lais de mise sur le march\u00e9 et am\u00e9liorer les taux d&#8217;approbation. Malgr\u00e9 cette dynamique, la majorit\u00e9 des laboratoires en sont encore au stade pilote, frein\u00e9s par des d\u00e9fis li\u00e9s \u00e0 la gestion des donn\u00e9es et \u00e0 la complexit\u00e9 des processus.<\/p>\n\n\n\n<p>Les entreprises leaders, qui ont d\u00e9j\u00e0 mis en \u0153uvre des transformations significatives, observent des r\u00e9sultats positifs tels que la r\u00e9duction des erreurs, l&#8217;optimisation des co\u00fbts et l&#8217;acc\u00e9l\u00e9ration de la mise sur le march\u00e9. En outre, ces laboratoires modernis\u00e9s contribuent \u00e9galement \u00e0 r\u00e9duire l&#8217;empreinte carbone, un avantage pour les organisations cherchant \u00e0 allier innovation scientifique et durabilit\u00e9.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p><a id=\"_ftn2\" href=\"#_ftnref2\">[1]<\/a> Les grandes entreprises pharmaceutiques sont d\u00e9finies comme celles dont le chiffre d&#8217;affaires annuel est sup\u00e9rieur ou \u00e9gal \u00e0 10 milliards de dollars.<\/p>\n\n\n\n<p><a id=\"_ftn1\" href=\"#_ftnref1\">[2]<\/a> &nbsp;Les laboratoires de nouvelle g\u00e9n\u00e9ration sont des laboratoires qui font \u00e9voluer en permanence leur technologie, leur infrastructure, leurs m\u00e9thodes de travail, leurs comp\u00e9tences et leur culture.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n\n\n<div class=\"wp-block-cg-blocks-cg-block-related-content\"><section class=\"relatedContentBlock\"><div class=\"container\"><div class=\"row\"><div class=\"content-title col-12 col-md-8\"><h2 class=\"related-content-heading\">Autres publications<\/h2><\/div><\/div><div class=\"row relatedContent\"><div class=\"col-lg-4 col-md-6 col-xs-12\">\n\t\t\t\t\t\t\t<div class=\"box\">\n\t\t\t\t\t\t\t\t<a aria-label=\"Lire la suite 85 % des entreprises clientes de banques pr\u00e9voient de faire appel \u00e0 une institution financi\u00e8re non bancaire dans l\u2019ann\u00e9e \u00e0 venir, alors que la concurrence avec les capitaux priv\u00e9s s\u2019intensifie\" href=\"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/85-des-entreprises-clientes-de-banques-prevoient-de-faire-appel-a-une-institution-financiere-non-bancaire-dans-lannee-a-venir-alors-que-la-concurrence-avec-les-capitaux-prives-sint\/\" class=\"anchorWrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"box-tag\"><span>Publications<\/span><\/span>\n\t\t\t\t\t\t\t\t\t<div class=\"box-title\"><h3 class=\"box-subtitle\">85 % des entreprises clientes de banques pr\u00e9voient de faire appel \u00e0 une institution financi\u00e8re non bancaire dans l\u2019ann\u00e9e \u00e0 venir, alors que la concurrence avec les capitaux priv\u00e9s s\u2019intensifie<\/h3><\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"box-date\">\n\t\t\t\t\t\t\t\t\t\t<span>Mar 16, 2026<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"box-bottom\">\n\t\t\t\t\t\t\t\t\t\t&lt;a class=&quot;link-download&quot; href=&quot;https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2026\/03\/03_16_WCIBR-Press-Release_FR.pdf&quot; aria-label=&quot;T\u00e9l\u00e9charger le communiqu\u00e9 de presse&quot; target=&quot;_blank&quot;  type=&quot;download&quot; title=&quot;Opens in a new window&quot;&gt;\n\t\t\t\t\t\t\t&lt;span&gt;T\u00e9l\u00e9charger le communiqu\u00e9 de presse&lt;\/span&gt;\n\t\t\t\t\t\t\t&lt;span&gt;142 KB PDF&lt;\/span&gt;\n\t\t\t\t\t\t&lt;\/a&gt;\n\t\t\t\t\t\t\t\t\t\t<a class=\"more\" aria-label=\"Lire la suite 85 % des entreprises clientes de banques pr\u00e9voient de faire appel \u00e0 une institution financi\u00e8re non bancaire dans l\u2019ann\u00e9e \u00e0 venir, alors que la concurrence avec les capitaux priv\u00e9s s\u2019intensifie\" href=\"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/85-des-entreprises-clientes-de-banques-prevoient-de-faire-appel-a-une-institution-financiere-non-bancaire-dans-lannee-a-venir-alors-que-la-concurrence-avec-les-capitaux-prives-sint\/\">Lire la suite<\/a>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div><div class=\"col-lg-4 col-md-6 col-xs-12\">\n\t\t\t\t\t\t\t<div class=\"box\">\n\t\t\t\t\t\t\t\t<a aria-label=\"Lire la suite Passant de l\u2019engouement \u00e0 une approche plus r\u00e9aliste, les organisations augmentent leurs investissements en IA et visent la cr\u00e9ation de valeur \u00e0 long terme\" href=\"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/passant-de-lengouement-a-une-approche-plus-realiste-les-organisations-augmentent-leurs-investissements-en-ia-et-visent-la-creation-de-valeur-a-long-terme\/\" class=\"anchorWrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"box-tag\"><span>Publications<\/span><\/span>\n\t\t\t\t\t\t\t\t\t<div class=\"box-title\"><h3 class=\"box-subtitle\">Passant de l\u2019engouement \u00e0 une approche plus r\u00e9aliste, les organisations augmentent leurs investissements en IA et visent la cr\u00e9ation de valeur \u00e0 long terme<\/h3><\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"box-date\">\n\t\t\t\t\t\t\t\t\t\t<span>Jan 15, 2026<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"box-bottom\">\n\t\t\t\t\t\t\t\t\t\t&lt;a class=&quot;link-download&quot; href=&quot;https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2026\/01\/01_15-Capgemini-AI-perspectives-and-AI-in-CXO-decision-making-press-release_FR.pdf&quot; aria-label=&quot;T\u00e9l\u00e9charger le communiqu\u00e9 de presse&quot; target=&quot;_blank&quot;  type=&quot;download&quot; title=&quot;Opens in a new window&quot;&gt;\n\t\t\t\t\t\t\t&lt;span&gt;T\u00e9l\u00e9charger le communiqu\u00e9 de presse&lt;\/span&gt;\n\t\t\t\t\t\t\t&lt;span&gt;174 KB PDF&lt;\/span&gt;\n\t\t\t\t\t\t&lt;\/a&gt;\n\t\t\t\t\t\t\t\t\t\t<a class=\"more\" aria-label=\"Lire la suite Passant de l\u2019engouement \u00e0 une approche plus r\u00e9aliste, les organisations augmentent leurs investissements en IA et visent la cr\u00e9ation de valeur \u00e0 long terme\" href=\"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/passant-de-lengouement-a-une-approche-plus-realiste-les-organisations-augmentent-leurs-investissements-en-ia-et-visent-la-creation-de-valeur-a-long-terme\/\">Lire la suite<\/a>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div><div class=\"col-lg-4 col-md-6 col-xs-12\">\n\t\t\t\t\t\t\t<div class=\"box\">\n\t\t\t\t\t\t\t\t<a aria-label=\"Lire la suite Les consommateurs \u00e9quilibrent leurs d\u00e9penses entre les produits essentiels et de petits plaisirs qui procurent un r\u00e9confort \u00e9motionnel\" href=\"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/consumers\/\" class=\"anchorWrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"box-tag\"><span>Publications<\/span><\/span>\n\t\t\t\t\t\t\t\t\t<div class=\"box-title\"><h3 class=\"box-subtitle\">Les consommateurs \u00e9quilibrent leurs d\u00e9penses entre les produits essentiels et de petits plaisirs qui procurent un r\u00e9confort \u00e9motionnel<\/h3><\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"box-date\">\n\t\t\t\t\t\t\t\t\t\t<span>Jan 6, 2026<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"box-bottom\">\n\t\t\t\t\t\t\t\t\t\t&lt;a class=&quot;link-download&quot; href=&quot;https:\/\/www.capgemini.com\/wp-content\/uploads\/2026\/01\/01_06_Capgemini-news-alert_Consumer-Trends-report-1.pdf&quot; aria-label=&quot;T\u00e9l\u00e9charger le communiqu\u00e9 de presse&quot; target=&quot;_blank&quot;  type=&quot;download&quot; title=&quot;Opens in a new window&quot;&gt;\n\t\t\t\t\t\t\t&lt;span&gt;T\u00e9l\u00e9charger le communiqu\u00e9 de presse&lt;\/span&gt;\n\t\t\t\t\t\t\t&lt;span&gt;145 KB PDF&lt;\/span&gt;\n\t\t\t\t\t\t&lt;\/a&gt;\n\t\t\t\t\t\t\t\t\t\t<a class=\"more\" aria-label=\"Lire la suite Les consommateurs \u00e9quilibrent leurs d\u00e9penses entre les produits essentiels et de petits plaisirs qui procurent un r\u00e9confort \u00e9motionnel\" href=\"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/consumers\/\">Lire la suite<\/a>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div><\/div><\/div><\/section><\/div>","protected":false},"excerpt":{"rendered":"<p>Les organisations pharmaceutiques repensent leur approche de la configuration et des op\u00e9rations de leurs laboratoires, en mettant l&#8217;accent sur l&#8217;acc\u00e9l\u00e9ration de la num\u00e9risation, l&#8217;exploitation de l&#8217;IA, l&#8217;am\u00e9lioration des processus et la mise en place des comp\u00e9tences et de la culture ad\u00e9quates pour une transformation des laboratoires. <\/p>\n","protected":false},"author":387,"featured_media":742480,"template":"","meta":{"cg_dt_proposed_to":[21,41],"cg_seo_hreflang_relations":"[]","cg_seo_canonical_relation":"{\"uuid\":\"f6041732-002d-473e-b806-89096aa9de1d\",\"blogId\":\"\",\"domain\":\"\",\"sitePath\":\"\",\"postLink\":\"\",\"postId\":null,\"isSaved\":true,\"isCrossLink\":false,\"hasCrossLink\":false}","cg_seo_hreflang_x_default_relation":"{\"uuid\":\"0cef272c-85c5-43a3-b16c-5ddf5bcdd838\",\"blogId\":\"\",\"domain\":\"\",\"sitePath\":\"\",\"postLink\":\"\",\"postId\":null,\"isSaved\":true,\"isCrossLink\":false,\"hasCrossLink\":false}","cg_dt_approved_content":true,"cg_dt_mandatory_content":false,"cg_dt_notes":"","cg_dg_source_changed":true,"cg_dt_link_disabled":true,"footnotes":"","related_resource_url":"https:\/\/www.capgemini.com\/wp-content\/uploads\/2024\/02\/02_07_Lab-of-the-future_Group-news-alert.pdf","related_resource_id":990351,"related_resource_size":"149 KB","related_resource_type":"pdf","cg_author":0,"featured_focal_points":""},"tags":[],"press-release-type":[87],"brand":[368],"class_list":["post-742462","press-release","type-press-release","status-publish","has-post-thumbnail","hentry","press-release-type-publications","brand-capgemini-research-institute"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.8 (Yoast SEO v22.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Les grandes entreprises pharmaceutiques investiront pr\u00e8s de 7% de leur chiffre d&#039;affaires dans la cr\u00e9ation d&#039;environnements de laboratoire connect\u00e9s et de pointe d&#039;ici \u00e0 2025 - Capgemini France<\/title>\n<meta name=\"description\" content=\"Les grandes entreprises pharmaceutiques investiront dans la cr\u00e9ation d&#039;environnements de laboratoire connect\u00e9s et de pointe d&#039;ici \u00e0 2025\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Les grandes entreprises pharmaceutiques investiront pr\u00e8s de 7% de leur chiffre d&#039;affaires dans la cr\u00e9ation d&#039;environnements de laboratoire connect\u00e9s et de pointe d&#039;ici \u00e0 2025\" \/>\n<meta property=\"og:description\" content=\"Les grandes entreprises pharmaceutiques investiront dans la cr\u00e9ation d&#039;environnements de laboratoire connect\u00e9s et de pointe d&#039;ici \u00e0 2025\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/\" \/>\n<meta property=\"og:site_name\" content=\"Capgemini France\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-04T07:44:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/02\/2024-FR-Webpreview-CRI-Lab-of-the-Future.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/\",\"url\":\"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/\",\"name\":\"Les grandes entreprises pharmaceutiques investiront pr\u00e8s de 7% de leur chiffre d'affaires dans la cr\u00e9ation d'environnements de laboratoire connect\u00e9s et de pointe d'ici \u00e0 2025 - Capgemini France\",\"isPartOf\":{\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/02\/test-3.jpg\",\"datePublished\":\"2024-02-07T07:30:00+00:00\",\"dateModified\":\"2025-03-04T07:44:29+00:00\",\"description\":\"Les grandes entreprises pharmaceutiques investiront dans la cr\u00e9ation d'environnements de laboratoire connect\u00e9s et de pointe d'ici \u00e0 2025\",\"breadcrumb\":{\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/#primaryimage\",\"url\":\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/02\/test-3.jpg\",\"contentUrl\":\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/02\/test-3.jpg\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Press Releases\",\"item\":\"https:\/\/www.capgemini.com\/fr-fr\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Les grandes entreprises pharmaceutiques investiront pr\u00e8s de 7% de leur chiffre d&#8217;affaires dans la cr\u00e9ation d&#8217;environnements de laboratoire connect\u00e9s et de pointe d&#8217;ici \u00e0 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/#website\",\"url\":\"https:\/\/www.capgemini.com\/fr-fr\/\",\"name\":\"Capgemini France\",\"description\":\"Just another www.capgemini.com site\",\"publisher\":{\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.capgemini.com\/fr-fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/#organization\",\"name\":\"Capgemini France\",\"url\":\"https:\/\/www.capgemini.com\/fr-fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2022\/08\/Logo-Capgemini.png\",\"contentUrl\":\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2022\/08\/Logo-Capgemini.png\",\"width\":202,\"height\":60,\"caption\":\"Capgemini France\"},\"image\":{\"@id\":\"https:\/\/www.capgemini.com\/fr-fr\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Les grandes entreprises pharmaceutiques investiront pr\u00e8s de 7% de leur chiffre d'affaires dans la cr\u00e9ation d'environnements de laboratoire connect\u00e9s et de pointe d'ici \u00e0 2025 - Capgemini France","description":"Les grandes entreprises pharmaceutiques investiront dans la cr\u00e9ation d'environnements de laboratoire connect\u00e9s et de pointe d'ici \u00e0 2025","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/","og_locale":"fr_FR","og_type":"article","og_title":"Les grandes entreprises pharmaceutiques investiront pr\u00e8s de 7% de leur chiffre d'affaires dans la cr\u00e9ation d'environnements de laboratoire connect\u00e9s et de pointe d'ici \u00e0 2025","og_description":"Les grandes entreprises pharmaceutiques investiront dans la cr\u00e9ation d'environnements de laboratoire connect\u00e9s et de pointe d'ici \u00e0 2025","og_url":"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/","og_site_name":"Capgemini France","article_modified_time":"2025-03-04T07:44:29+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/02\/2024-FR-Webpreview-CRI-Lab-of-the-Future.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/","url":"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/","name":"Les grandes entreprises pharmaceutiques investiront pr\u00e8s de 7% de leur chiffre d'affaires dans la cr\u00e9ation d'environnements de laboratoire connect\u00e9s et de pointe d'ici \u00e0 2025 - Capgemini France","isPartOf":{"@id":"https:\/\/www.capgemini.com\/fr-fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/#primaryimage"},"image":{"@id":"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/#primaryimage"},"thumbnailUrl":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/02\/test-3.jpg","datePublished":"2024-02-07T07:30:00+00:00","dateModified":"2025-03-04T07:44:29+00:00","description":"Les grandes entreprises pharmaceutiques investiront dans la cr\u00e9ation d'environnements de laboratoire connect\u00e9s et de pointe d'ici \u00e0 2025","breadcrumb":{"@id":"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/#primaryimage","url":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/02\/test-3.jpg","contentUrl":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/02\/test-3.jpg","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Press Releases","item":"https:\/\/www.capgemini.com\/fr-fr\/news\/"},{"@type":"ListItem","position":2,"name":"Les grandes entreprises pharmaceutiques investiront pr\u00e8s de 7% de leur chiffre d&#8217;affaires dans la cr\u00e9ation d&#8217;environnements de laboratoire connect\u00e9s et de pointe d&#8217;ici \u00e0 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.capgemini.com\/fr-fr\/#website","url":"https:\/\/www.capgemini.com\/fr-fr\/","name":"Capgemini France","description":"Just another www.capgemini.com site","publisher":{"@id":"https:\/\/www.capgemini.com\/fr-fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.capgemini.com\/fr-fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.capgemini.com\/fr-fr\/#organization","name":"Capgemini France","url":"https:\/\/www.capgemini.com\/fr-fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.capgemini.com\/fr-fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2022\/08\/Logo-Capgemini.png","contentUrl":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2022\/08\/Logo-Capgemini.png","width":202,"height":60,"caption":"Capgemini France"},"image":{"@id":"https:\/\/www.capgemini.com\/fr-fr\/#\/schema\/logo\/image\/"}}]}},"parsely":{"version":"1.1.0","canonical_url":"https:\/\/capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/","smart_links":{"inbound":0,"outbound":0},"traffic_boost_suggestions_count":0,"meta":{"@context":"https:\/\/schema.org","@type":"NewsArticle","headline":"Les grandes entreprises pharmaceutiques investiront pr\u00e8s de 7% de leur chiffre d&#8217;affaires dans la cr\u00e9ation d&#8217;environnements de laboratoire connect\u00e9s et de pointe d&#8217;ici \u00e0 2025","url":"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/","mainEntityOfPage":{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/"},"thumbnailUrl":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/02\/test-3.jpg?w=150&h=150&crop=1","image":{"@type":"ImageObject","url":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/02\/test-3.jpg"},"articleSection":"Uncategorized","author":[],"creator":[],"publisher":{"@type":"Organization","name":"Capgemini France","logo":""},"keywords":[],"dateCreated":"2024-02-07T07:30:00Z","datePublished":"2024-02-07T07:30:00Z","dateModified":"2025-03-04T07:44:29Z"},"rendered":"<meta name=\"parsely-title\" content=\"Les grandes entreprises pharmaceutiques investiront pr\u00e8s de 7% de leur chiffre d&#8217;affaires dans la cr\u00e9ation d&#8217;environnements de laboratoire connect\u00e9s et de pointe d&#8217;ici \u00e0 2025\" \/>\n<meta name=\"parsely-link\" content=\"https:\/\/www.capgemini.com\/fr-fr\/actualites\/communiques-de-presse\/les-grandes-entreprises-pharma-investiront-dans-la-construction-de-labo-de-pointe\/\" \/>\n<meta name=\"parsely-type\" content=\"post\" \/>\n<meta name=\"parsely-image-url\" content=\"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/02\/test-3.jpg?w=150&amp;h=150&amp;crop=1\" \/>\n<meta name=\"parsely-pub-date\" content=\"2024-02-07T07:30:00Z\" \/>\n<meta name=\"parsely-section\" content=\"Uncategorized\" \/>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/capgemini.com\/p.js"},"archive_status":false,"featured_image_src":"https:\/\/www.capgemini.com\/fr-fr\/wp-content\/uploads\/sites\/6\/2024\/02\/test-3.jpg","featured_image_alt":"","jetpack_sharing_enabled":true,"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Capgemini France","distributor_original_site_url":"https:\/\/www.capgemini.com\/fr-fr","push-errors":false,"tag_names":[],"_links":{"self":[{"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/press-release\/742462","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/press-release"}],"about":[{"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/types\/press-release"}],"author":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/users\/387"}],"version-history":[{"count":8,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/press-release\/742462\/revisions"}],"predecessor-version":[{"id":777125,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/press-release\/742462\/revisions\/777125"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/media\/742480"}],"wp:attachment":[{"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/media?parent=742462"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/tags?post=742462"},{"taxonomy":"press-release-type","embeddable":true,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/press-release-type?post=742462"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/www.capgemini.com\/fr-fr\/wp-json\/wp\/v2\/brand?post=742462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}